By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XenoPort, Inc. 

3410 Central Expressway

Santa Clara  California  95051  U.S.A.
Phone: 408-616-7200 Fax: 408-616-7210


Company News
XenoPort, Inc. (XNPT) To Present Data For Novel Fumarate Analog XP23829 At The 2014 Joint ACTRIMS-ECTRIMS Meeting In Boston 9/10/2014 10:18:23 AM
XenoPort, Inc. (XNPT) And The NIAAA Announce Clinical Trial Agreement To Study HORIZANT As A Potential Treatment For Alcohol Use Disorder 9/9/2014 10:42:36 AM
XenoPort, Inc. (XNPT) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/2/2014 10:54:17 AM
XenoPort, Inc. (XNPT) Reports Second Quarter Financial Results 8/7/2014 10:39:24 AM
XenoPort, Inc. (XNPT) To Release Second Quarter Financial Results on August 6, 2014 7/22/2014 3:54:03 PM
XenoPort, Inc. (XNPT) Announces Initiation Of A Phase 2 Clinical Trial Of XP23829 In Patients With Psoriasis 6/23/2014 8:32:49 AM
XenoPort, Inc. (XNPT) To Present At The 2014 Wells Fargo Healthcare Conference 6/9/2014 11:23:30 AM
XenoPort, Inc. (XNPT) Mails Letter To Stockholders Highlighting ISS’s Recommendation That Xenoport Stockholders Vote “FOR ALL” Of Xenoport’s Director Nominees On The WHITE Card 6/3/2014 10:08:07 AM
Leading Independent Proxy Advisory Firm ISS Recommends XenoPort, Inc. (XNPT) Stockholders Vote FOR ALL XenoPort Director Nominees 5/30/2014 9:34:46 AM
XenoPort, Inc. (XNPT) To Present At The Jefferies 2014 Global Healthcare Conference 5/27/2014 9:49:25 AM